Cardiovascular Outcome Trials with Glucose-Lowering Drugs

被引：0
|
作者：
Tina K. Thethi
Anika Bilal
Richard E. Pratley
机构：
[1] AdventHealth Translational Research Institute,
[2] AdventHealth Diabetes Institute,undefined
来源：
Current Cardiology Reports | 2021年 / 23卷
关键词：
Cardiovascular outcome trials; Thiazolidinediones, Dipeptidyl peptidase-4 inhibitors; Glucagon-like peptide-1 receptors agonists; Sodium-glucose cotransporter 2 inhibitors; Insulin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Association between novel Glucose-Lowering drugs and risk of Asthma: A network Meta-Analysis of cardiorenal outcome trials
    Wang, Aihua
    Tang, Huilin
    Zhang, Ning
    Feng, Xin
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 183
  • [42] Newer Glucose-Lowering Drugs and Risk of Parkinson's Disease-A Meta-analysis of Randomized Outcome Trials
    Tang, Huilin
    Lu, Ying
    Donahoo, William T.
    Okun, Michael S.
    Wang, Fei
    Bian, Jiang
    Guo, Jingchuan
    DIABETES, 2023, 72
  • [43] The impact of glucose-lowering therapy on cardiovascular outcomes
    Standl, Eberhard
    Mueller, Martin
    Schnell, Oliver
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (03) : 401 - 411
  • [44] LEADER and the new 'cardiovascular' glucose-lowering agents
    Livingstone, Rachel
    Boyle, James G.
    Petrie, John R.
    PRACTICAL DIABETES, 2016, 33 (06) : 187 - 189
  • [45] The impact of glucose-lowering medications on cardiovascular disease
    Avogaro, Angelo
    De Kreutzenberg, Saula Vigili
    Fadini, Gian Paolo
    CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM, 2018, 7 (01): : 13 - 17
  • [46] From glucose lowering to treatment of cardiovascular disease: the repositioning of glucose-lowering agents
    Caprio, Massimiliano
    Vitale, Cristiana
    Rosano, Giuseppe M. C.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (02) : 83 - 85
  • [47] A Review of Cardiovascular Outcomes Trials of Glucose-Lowering Therapies and Their Effects on Heart Failure Outcomes
    Nassif, Michael E.
    Kosiborod, Mikhail
    AMERICAN JOURNAL OF MEDICINE, 2019, 132 (10): : S13 - S20
  • [48] Pragmatic trials, a step forward to assess cardiovascular efficacy of new glucose-lowering agents
    Scheen, Andre
    LANCET DIABETES & ENDOCRINOLOGY, 2023, 11 (09): : 626 - 627
  • [49] A Review of Cardiovascular Outcomes Trials of Glucose-Lowering Therapies and Their Effects on Heart Failure Outcomes
    Nassif, Michael E.
    Kosiborod, Mikhail
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 124 : S12 - S19
  • [50] Cardiovascular Effects of Glucose-lowering Therapies for Type 2 Diabetes: New Drugs in Perspective
    Thompson, Peter L.
    Davis, Timothy M. E.
    CLINICAL THERAPEUTICS, 2017, 39 (05) : 1012 - 1025
12345